UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Statement
Sales, net	$ 10,002	$ 10,025	$ 20,376	$ 21,230
Cost of goods sold	3,954	3,954	8,047	8,421
Gross profit	6,048	6,071	12,329	12,809
Operating expense:
Selling, general and administrative	2,213	2,372	4,482	4,850
Research and development	120	147	243	293
Total operating expense	2,333	2,519	4,725	5,143
Operating income	3,715	3,552	7,605	7,667
Other income (expense)	(89)	(122)	(191)	(300)
Income before provision for income taxes	3,627	3,430	7,414	7,367
Provision for income taxes	994	1,029	2,046	2,177
Net income	2,632	2,401	5,368	5,190
Earnings per common share (basic)	$ 0.71	$ 0.65	$ 1.44	$ 1.42
Earnings per common share (diluted)	$ 0.70	$ 0.65	$ 1.43	$ 1.41
Shares outstanding (basic)	3,725	3,678	3,718	3,663
Shares outstanding (diluted)	3,770	3,711	3,764	3,694
Other comprehensive income:
Foreign currency translation net of taxes of $0 in all periods	19	(949)	(2,497)	244
Unrealized gain (loss) on investments net of taxes of $2, $(3), $4 and $3	2	(5)	5	4
Total comprehensive income	$ 2,654	$ 1,447	$ 2,876	$ 5,438